Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 5/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.50 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1041473 | 1.00 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| SCHEMBL29195226 | 1.00 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| SCHEMBL4556223 | 1.00 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| Hydrogen Peroxide SCHEMBL14842577 | 1.00 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| SCHEMBL60129 | 1.00 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| SCHEMBL1040024 | 1.00 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| SCHEMBL1109741 | 0.97 | OPRL1 (0.57) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| SCHEMBL1724862 | 0.92 | OPRL1 (0.57) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| Ethylene Glycol SCHEMBL28317982 | 0.91 | OPRL1 (0.49) | OPRL1OPRM1OPRK1OPRD1AKR1C1 | |
| Ammonia Solution, Strong SCHEMBL29195223 | 0.90 | OPRL1 (0.55) | OPRL1OPRM1OPRK1OPRD1AKR1C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9796740-B2 | Liquid bisacylphosphine oxide photoinitiator | BASF SE (DE) | 2017-10-24 | — | — | US | disclosed |
| US-9696475-B2 | Optical film | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-07-04 | — | — | US | disclosed |
| US-20160168177-A1 | LIQUID BISACYLPHOSPHINE OXIDE PHOTOINITIATOR | IGM GROUP B.V. (NL) | 2016-06-16 | — | — | US | disclosed |
| US-20150049291-A1 | OPTICAL FILM | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168177-A1 | LIQUID BISACYLPHOSPHINE OXIDE PHOTOINITIATOR | CCNY, CCNT2, CCNE2 | OPRL1 493/4885OPRM1 328/4885OPRK1 580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.